← Leaderboards
Jerrold J. Ellner
Univ Of Med/Dent Of Nj-Nj Medical School
$53,718,214
Attributed
$91,159,500
Total exposure
15
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $14.1M · FY2005–25$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$128,029,049 · 16
CDC$330,073 · 1
By mechanism
U19$38,020,878 · 3
U01$37,026,168 · 3
R01$27,605,768 · 7
N01$22,001,072 · 1
D43$2,235,321 · 1
UH2$1,139,842 · 1
Top collaborators
- David Alland42 shared
- Padmini Salgame31 shared
- Susan E Dorman12 shared
- Moses Lutaakome Joloba6 shared
- Bruno De Bezerril Andrade3 shared
- Timothy R Sterling3 shared
- Vojo P Deretic2 shared
- Linda A. Felton1 shared
Others in their field
Top investigators on “Tuberculosis”
- Judith S. Currier · University Of California Los Angeles$301,722,065
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$297,204,160
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$267,912,117
- Lawrence Corey · Fred Hutchinson Cancer Center$255,939,398
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$200,192,298
- Sharon A Nachman · Johns Hopkins University$194,852,226
Research focus
TuberculosisMycobacterium TuberculosisProgramsTuberculosis TreatmentPharmaceutical PreparationsUgandaResponseSiteDrug ResistanceDiagnosticNovel DiagnosticsInfectionPhenotypeSamplingClinical TrialsDesignResearch PersonnelDiagnosisImmune ResponseBaseInnovationLaboratoriesCountryFunding
Grant awards (90)
TB-RICC 3.0$3,925,093
U01 · FY2025 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$2,722,689
U19 · FY2025 · AI
FEND-TB$2,593,818
R01 · FY2025 · AI · contact PI
Bacteria and Host in TB Transmission$1,612,367
R01 · FY2025 · AI
FEND-TB$298,587
R01 · FY2025 · AI · contact PI
FEND-TB$196,955
R01 · FY2025 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$38,013
U19 · FY2025 · AI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$8,125
U19 · FY2025 · AI
TB-RICC 3.0$3,960,184
U01 · FY2024 · AI · contact PI
FEND for TB$3,689,474
U01 · FY2024 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$2,749,420
U19 · FY2024 · AI
Novel and Optimized Diagnostics for Pediatric TB$1,142,223
R01 · FY2024 · AI · contact PI
FEND for TB$3,943,297
U01 · FY2023 · AI · contact PI
TB-RICC 3.0$3,933,417
U01 · FY2023 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$2,658,286
U19 · FY2023 · AI
Bacteria and Host in TB Transmission$1,697,099
R01 · FY2023 · AI
Novel and Optimized Diagnostics for Pediatric TB$1,088,847
R01 · FY2023 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$339,935
U19 · FY2023 · AI
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases$226,436
D43 · FY2023 · TW · contact PI
Novel and Optimized Diagnostics for Pediatric TB$219,999
R01 · FY2023 · AI · contact PI
FEND for TB$4,167,230
U01 · FY2022 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$2,658,286
U19 · FY2022 · AI
Bacteria and Host in TB Transmission$1,816,206
R01 · FY2022 · AI
Novel and Optimized Diagnostics for Pediatric TB$1,122,443
R01 · FY2022 · AI · contact PI
Bacterial and host determinants of progression, manifestations and consequences of TB$429,311
U19 · FY2022 · AI · contact PI
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases$264,588
D43 · FY2022 · TW · contact PI
Novel and Optimized Diagnostics for Pediatric TB$219,999
R01 · FY2022 · AI · contact PI
Bacteria and Host in TB Transmission$219,999
R01 · FY2022 · AI
FEND for TB supplement to accelerate BLINK X development$218,451
U01 · FY2022 · AI · contact PI
FEND for TB$3,954,651
U01 · FY2021 · AI · contact PI
Bacterial and Host Heterogeneity in TB latency, persistence and progression$2,751,534
U19 · FY2021 · AI
Bacteria and Host in TB Transmission$1,695,066
R01 · FY2021 · AI
Novel and Optimized Diagnostics for Pediatric TB$1,119,258
R01 · FY2021 · AI · contact PI
Bacterial and host determinants of progression, manifestations and consequences of TB$391,945
U19 · FY2021 · AI · contact PI
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases$294,442
D43 · FY2021 · TW · contact PI
FEND for TB$3,998,028
U01 · FY2020 · AI · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,457,326
U19 · FY2020 · AI · contact PI
Bacteria and Host in TB Transmission$1,637,992
R01 · FY2020 · AI
Novel and Optimized Diagnostics for Pediatric TB$1,085,066
R01 · FY2020 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$556,523
R01 · FY2020 · AI
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases$294,048
D43 · FY2020 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,665,571
U19 · FY2019 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,180,603
R01 · FY2019 · AI
Training of Ugandans in Basic and Translational Research on TB and Emerging Infectious Diseases$294,749
D43 · FY2019 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$2,399,184
U19 · FY2018 · AI · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$1,413,190
U19 · FY2018 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,325,755
R01 · FY2018 · AI
Impact of Pregnancy on Tuberculosis$423,909
R01 · FY2018 · AI · contact PI
Impact of Pregnancy on Tuberculosis$241,484
R01 · FY2018 · AI · contact PI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases$185,878
D43 · FY2018 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,064,926
U19 · FY2017 · AI · contact PI
Accuracy of the Xpert Ultra for Diagnosis of Pulmonary Tuberculosis$1,424,115
R01 · FY2017 · AI
Impact of Pregnancy on Tuberculosis$592,746
R01 · FY2017 · AI · contact PI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases$178,168
D43 · FY2017 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,078,872
U19 · FY2016 · AI · contact PI
Impact of Pregnancy on Tuberculosis$679,173
R01 · FY2016 · AI · contact PI
Autophagy-based HDT for tuberculosis$561,389
UH2 · FY2016 · AI
TB Clinical Diagnostics Research Consortium$395,907
N01 · FY2016 · AI · contact PI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases$183,298
D43 · FY2016 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,050,511
U19 · FY2015 · AI · contact PI
TB Clinical Diagnostics Research Consortium$2,732,315
N01 · FY2015 · AI · contact PI
Impact of Pregnancy on Tuberculosis$642,186
R01 · FY2015 · AI · contact PI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS$605,604
U01 · FY2015 · AI · contact PI
Autophagy-based HDT for tuberculosis$578,453
UH2 · FY2015 · AI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases$175,141
D43 · FY2015 · TW · contact PI
Biomarkers and Mechanisms of Paucibacillary and Latent Tuberculosis$3,143,754
U19 · FY2014 · AI · contact PI
TB Clinical Diagnostics Research Consortium$2,883,693
N01 · FY2014 · AI · contact PI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS$605,629
U01 · FY2014 · AI · contact PI
Training of Ugandans in Basic Research on TB and Emerging Infectious Diseases$138,573
D43 · FY2014 · TW · contact PI
TB Clinical Diagnostics Research Consortium$2,816,254
N01 · FY2013 · AI · contact PI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS$569,292
U01 · FY2013 · AI · contact PI
TB Clinical Diagnostics Research Consortium$2,939,729
N01 · FY2012 · AI · contact PI
TB Clinical Diagnostics Research Consortium$4,307,640
N01 · FY2011 · AI · contact PI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS$596,258
U01 · FY2011 · AI · contact PI
TB Clinical Diagnostics Research Consortium$3,035,645
N01 · FY2010 · AI · contact PI
US BRAZIL COLLABORATION ON IMMUNITY AND BIOMARKERS IN TUBERCULOSIS$506,339
U01 · FY2010 · AI · contact PI
HUMAN IMMUNODEFICIENCY VIRUS(HIV) PREVENTION PROJECTS FOR COMMUNITY BASED ORGS$330,073
U65 · FY2010 · PS · contact PI
TB Clinical Diagnostics Research Consortium$2,889,889
N01 · FY2009 · AI · contact PI
US-Brazil Research Collaboration on Strain Variation in TB$483,545
U01 · FY2009 · AI · contact PI
US-Brazil Research Collaboration on Strain Variation in TB$482,095
U01 · FY2008 · AI · contact PI
US-Brazil Research Collaboration on Strain Variation in TB$483,522
U01 · FY2007 · AI · contact PI
US-Brazil Research Collaboration on Strain Variation in TB$491,413
U01 · FY2006 · AI · contact PI
US-Brazil Research Collaboration on Strain Variation in TB$412,646
U01 · FY2005 · AI
EXPRESSION OF TUBERCULOSIS IN THE LUNG$462,590
R01 · FY2004 · HL
EXPRESSION OF TUBERCULOSIS IN THE LUNG$455,392
R01 · FY2003 · HL
EXPRESSION OF TUBERCULOSIS IN THE LUNG$447,557
R01 · FY2002 · HL
EXPRESSION OF TUBERCULOSIS IN THE LUNG$424,448
R01 · FY2001 · HL
MYCOBACTERIAL DISEASES IN AIDS$282,018
R01 · FY2001 · AI
EXPRESSION OF TUBERCULOSIS IN THE LUNG$427,540
R01 · FY2000 · HL
MYCOBACTERIAL DISEASES IN AIDS$273,805
R01 · FY2000 · AI